SUPER AGERS (Part 2): Eric Topol on Sleep, GLP-1s, and AI
In part two of our interview with Eric Topol, author of the New York Times bestseller “Super Agers” , we cover how to get a good night’s sleep, why one day everyone may take GLP-1s, and how AI is poised to transform medicine.
“Super Agers: An Evidence-Based Approach to Longevity” is available on Amazon: https://geni.us/nM38U
1️⃣ Missed Part 1? Listen now on Apple Podcasts (https://podcasts.apple.com/us/podcast/the-next-big-idea/id1482067226?i=1000717684717) or Spotify (https://open.spotify.com/episode/48jabKauMX7EEx9z51Kq21?si=055e0e2376ab4701)
Key moments:
03:54 🌊 Microplastics in air, water, and food can fuel inflammation and raise heart and stroke risks.
07:03 🛌 Aim for about 7 hours of sleep to clear brain waste; less can boost dementia and heart disease odds.
12:17 🍷 Moderate drinking may hinder sleep but can enrich social connections, which benefit overall health.
18:36 💊 GLP-1 drugs aid weight loss, reduce inflammation, and could help with migraines and addiction.
21:29 🔬 Proactive prevention, rather than reacting to disease, is key for healthier aging.
21:45 🧠 Genetic checks, blood markers (PTA 217), and lifestyle steps show promise in heading off Alzheimer’s.
26:36 🤖 AI can streamline paperwork, sharpen diagnoses, and free doctors for more human-centered care.
31:09 👥 Personalized tests (DEXA, lipids, polygenic risk) help catch and address potential issues early.
📚 Become an executive member of the Next Big Idea Club, and we’ll send you a copy of Super Agers, along with the seven other best books of the year as chosen by our curators: Malcolm Gladwell, Adam Grant, Susan Cain, and Daniel Pink. Use code PODCAST to take 20% off your subscription
✉️ Sign up for our Book of the Day newsletter (https://bookoftheday.nextbigideaclub.com/?utm_source=nbidaily&utm_medium=shownotes)
